| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |